Mostrar el registro sencillo del ítem

Artículo

dc.creatorIglesias Blanco, Nieves
dc.creatorGalbis Fuster, Elsa
dc.creatorDíaz Blanco, Manuel Jesús
dc.creatorPaz Báñez, María Violante de
dc.creatorGalbis Pérez, Juan Antonio
dc.date.accessioned2024-01-26T08:27:27Z
dc.date.available2024-01-26T08:27:27Z
dc.date.issued2018-10-25
dc.identifier.citationIglesias Blanco, N., Galbis Fuster, E., Díaz Blanco, M.J., Paz Báñez, M.V.d. y Galbis Pérez, J.A. (2018). Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny. International Journal of Pharmaceutics, 550 (1-2), 429-438. https://doi.org/10.1016/j.ijpharm.2018.08.026.
dc.identifier.issn0378-5173es
dc.identifier.issn1873-3476es
dc.identifier.urihttps://hdl.handle.net/11441/154044
dc.description.abstractIn recent years, the preparation of valuable drug delivery systems (DDS) from self-assembled amphiphilic copolymers has attracted much attention since these nanomaterials provide new opportunities to solve problems such as the lack of solubility in water of lipophilic drugs, improve their bioavailability, prolong their circulation time and decrease the side effects associated with their administration. In the current study two types of biocompatible pH-responsive nanoparticles derived from poly(2-hydroxyethyl methacrylate) (pHEMA) have been used as drug nano-carriers, being one of them core cross-linked to circumvent their instability upon dilution in human fluids. The present paper deals with the optimization of the loading process of the labile, hydrophobic and highly active anticancer drug, Camptothecin (CPT) into the nanoparticles with regard to four independent variables: CPT/polymer ratio, sonication, temperature and loading time. Forty experiments were carried out and a Box–Behnken experimental design was used to evaluate the significance of the independent variables related to encapsulation efficiency and drug retention capacity. The enhanced drug loading and encapsulation efficiency values (58% and > 92%, respectively) of CPT were achieved by the core cross-linked NPs in 2 h at 32 °C at CPT/ polymer ratio 1.5:1 w/w and 14 min of sonication. The optimized CPT-loaded NPs were studied by dynamic light scattering and scanning electron microscopy, and an increase in size of the loaded-NP compared to the unloaded counterparts was found. Other twenty experiments were conducted to study the enability to retain CPT into the conjugates at different ionic strength values and times. The stability studies demonstrated that the core crosslinked nanocarriers displayed an excellent drug retention capacity (> 90%) at 25 °C for 15 days in every ionicstrength environments whereas the non-cross-linked ones were more stable at physiological ionic strength. The optimized systems proved to be a major step forward to encapsulate and retain CPT in the NP nuclei, what makes them ideal devices to control the delivery of CPT upon the triggered acidic conditions of solid tumors.es
dc.description.sponsorshipMinisterio de Economía y Competitividad de España - MAT2016-77345-C3-2-Pes
dc.description.sponsorshipJunta de Andalucía - P12-FQM-1553es
dc.formatapplication/pdfes
dc.format.extent10 p.es
dc.language.isoenges
dc.publisherElsevieres
dc.relation.ispartofInternational Journal of Pharmaceutics, 550 (1-2), 429-438.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectKinetic drug loadinges
dc.subjectpolyHEMAes
dc.subjectpH-responsive nanoparticleses
dc.subjectDrug delivery systemses
dc.subjectAnticancer therapyes
dc.subjectCore cross-linked nanoparticleses
dc.subjectExperimental designes
dc.titleLoading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutinyes
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/acceptedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Química Orgánica y Farmacéuticaes
dc.relation.projectIDMAT2016-77345-C3-2-Pes
dc.relation.projectIDP12-FQM-1553es
dc.relation.publisherversionhttps://doi.org/10.1016/j.ijpharm.2018.08.026es
dc.identifier.doi10.1016/j.ijpharm.2018.08.026es
dc.journaltitleInternational Journal of Pharmaceuticses
dc.publication.volumen550es
dc.publication.issue1-2es
dc.publication.initialPage429es
dc.publication.endPage438es
dc.contributor.funderMinisterio de Economía y Competitividad (MINECO). Españaes
dc.contributor.funderJunta de Andalucíaes

FicherosTamañoFormatoVerDescripción
Loading studies.pdf802.6KbIcon   [PDF] Ver/Abrir   Versión aceptada

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional